You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BC-ABL Positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Completed
  • Chronic Myeloid Leukemia
  • Stem Cell and Mutational Assay
  • Vancouver, British Columbia, Canada
    Leukemia BMT program of BC, Vancouver General Hospital, Hematolo
Apr 29, 2021

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +7 more
    • Blinatumomab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    HER2-positive Breast Cancer Trial in Guanzhou (Eribulin mesylate injection?Pertuzumab?Trastuzumab)

    Recruiting
    • HER2-positive Breast Cancer
    • Eribulin mesylate injection、Pertuzumab、Trastuzumab
    • Guanzhou, Guangdong, China
      LI YuDong
    Jul 13, 2023

    HER2-positive Breast Cancer Trial in Rome (PIK3CA analysis)

    Active, not recruiting
    • HER2-positive Breast Cancer
    • PIK3CA analysis
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Feb 20, 2023

    Breast Cancer, HER2-positive Trial in Houston (Zanidatamab, Letrozole, Tamoxifen)

    Recruiting
    • Breast Cancer
    • HER2-positive
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

    Active, not recruiting
    • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2022

    Breast Cancer, HER2-positive Breast Cancer Trial in Zhengzhou (Albumin paclitaxel+trastuzumab+pyrrolitinib,

    Active, not recruiting
    • Breast Cancer
    • HER2-positive Breast Cancer
    • Zhengzhou, Henan, China
      Henan cancer hospital
    Jun 23, 2023

    Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

    Not yet recruiting
    • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    • (no location specified)
    Jul 11, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Chicago, Illinois
    • +5 more
    Dec 27, 2021

    Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

    Completed
    • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    • Angers, France
    • +9 more
    Aug 17, 2022

    "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

    Not yet recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Sohag, Egypt
        Sohag University Hospital
      Sep 14, 2022

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 24, 2022

      Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

      Active, not recruiting
      • Chronic Myelogenous Leukemia
      • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
      • Boston, Massachusetts
      • +18 more
      Jan 19, 2023

      B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

      Completed
      • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 25, 2022

      Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

      Recruiting
      • Myeloproliferative Neoplasm
      • +2 more
      • Online Mindfulness Meditation
      • Internet-Based Webinars
      • San Francisco, California
        University of California San Francisco
      Aug 9, 2022

      HER2-positive Breast Cancer Trial in Xi'an (Pyrotinib)

      Recruiting
      • HER2-positive Breast Cancer
      • Xi'an, Shaanxi, China
        Jin Yang
      Jun 18, 2022

      Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Treatment-free Remission
      • TFR(Treatment-Free Remission)
      • (no location specified)
      Jun 27, 2022

      Asciminib RMP Study

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Asciminib
      • (no location specified)
      Jul 5, 2023

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

      Not yet recruiting
      • Breast Cancer
      • +2 more
      • Boston, Massachusetts
      • +2 more
      Nov 3, 2022

      Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Jena, Germany
        Universitätsklinikum Jena
      Jan 17, 2023

      Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive
        • Taipei, Taiwan
          National Taiwan University Hospital
        Jul 24, 2022